skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i team, is it possible for you to list no. of quarter earnings out of 8 beating estimate for all companies in your balance and growth portfolios. Deduct as many credits as it takes.
Read Answer Asked by victor on June 12, 2019
Q: Hello team,

On my trading platform, P/E is showing 45 and on the same platform they have a "Value Analyzer" Says the stock is under valued.

Is it possible that the stock is under valued even when the share price is at all time highs.

Your thoughts,

Thank you and have a great day!
Read Answer Asked by Rino on June 12, 2019
Q: While the market remains buoyant, Knight's CEO seems to be remaining patient for a major reset bringing potential buyout company prices spiralling downward. I am ok with that but he seems to have laid an egg with TherapeuticsMD by paying $20M for rights to just two of their drugs for Canada and Israel plus buying $20M of stock at $5.10 and is now down over 40% in a short time frame. What do you think of this deal and the potential of these drugs? It was, at least, good to see one company pay for rights to the rest of the world outside the US. Are they a legitimate partner?
Thanks.
Read Answer Asked by Steven on June 11, 2019
Q: I don’t like to add to my losers but the price drop of SIS makes it tempting. The stock is still an expensive one but do you think the dividend will start to give it some support? I’m concidering bringing this back up to a 2.5% position as I feel there’s lots of growth potential and I have a long time horizon.
Read Answer Asked by Dennis on June 11, 2019
Q: Sis recently reported AGM vote results and there were significant witheld votes for the 3 Bourassa members of the board, and highest for Robert. At the same time, performance continues to be good (as you note in recent report update). However, your full report notes key person risk for the Bourassa's. What can you tell us that would explain the withheld votes? Is this a trouble signal?
Read Answer Asked by John on June 11, 2019